Careers  |  Sign In  |  Register

AML Treatment Challenges Who, When, and How

Jorge Cortes, MD, director of the Georgia Cancer Center in Augusta, GA, provides a comprehensive look at the current challenges specialists face in providing optimal treatment for patients with acute myeloid leukemia (AML). Dr. Cortes also discusses some history of AML research and treatment, the most recent approvals of new therapies for certain patients with AML, and data from some of the recent clinical trials of the aforementioned therapies.


Brian A. Jonas, MD, PhD, FACP
Brian A. Jonas, MD, PhD, FACP

Associate Professor of Medicine

Chair, Hematologic Malignancies Disease Team Committee

Division of Hematology and Oncology

University of California Davis School of Medicine

Sacramento, CA

Gabriel N. Mannis, MD
Gabriel N. Mannis, MD

Assistant Professor of Medicine

Division of Hematology

Stanford Cancer Institute

Stanford University

Stanford, CA